Allergy Therapeutics plc (LON:AGY – Get Free Report) dropped 0.9% on Monday . The stock traded as low as GBX 5.25 ($0.07) and last traded at GBX 5.25 ($0.07). Approximately 557,008 shares traded hands during trading, a decline of 24% from the average daily volume of 729,353 shares. The stock had previously closed at GBX 5.30 ($0.07).
Allergy Therapeutics Trading Up 1.9 %
The company has a fifty day simple moving average of GBX 4.54 and a two-hundred day simple moving average of GBX 4.40. The company has a debt-to-equity ratio of 37.22, a current ratio of 1.40 and a quick ratio of 1.48. The company has a market capitalization of £252.81 million, a P/E ratio of -80.25, a price-to-earnings-growth ratio of -30.70 and a beta of 1.40.
About Allergy Therapeutics
Allergy Therapeutics plc, a commercial biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics.
Featured Stories
- Five stocks we like better than Allergy Therapeutics
- What is Short Interest? How to Use It
- Is McDonald’s Stock a Smart Buy After Sell-Off and Earnings?
- Using the MarketBeat Dividend Tax Calculator
- QuantumScape: Solid State EV Batteries Nearing Commercialization
- Stock Dividend Cuts Happen Are You Ready?
- MicroStrategy: Is This Bitcoin-Powered Stock a Buy or a Gamble?
Receive News & Ratings for Allergy Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergy Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
